NCT05715944View on ClinicalTrials.gov

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

PHASE3CompletedINTERVENTIONAL
Enrollment

10,888

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
COVID-19
Interventions
DRUG

AZD 1222

Vaccine

Trial Locations (1)

Unknown

Botswana Harvard Health Partnership, Gaborone

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Botswana Ministry of Health

OTHER_GOV

lead

Botswana Harvard AIDS Institute Partnership

OTHER